Case Study: Emerging Pharma achieves faster commercial analytics and launch readiness with Axtria

Emerging Pharma cuts data preparation time by 35% with Axtria

Emerging Pharma, a biopharma innovator in RNA-targeted therapeutics, faced challenges in commercializing its rare disease treatments due to scattered specialty pharmacy data, manual reporting, and limited patient journey visibility. To build a scalable data and analytics backbone for its upcoming product launches, the company partnered with Axtria.

Axtria implemented a unified commercial analytics platform featuring a governed data warehouse built on Databricks and powered by its Axtria DataMAx™ solution. This provided standardized data models and automated quality checks. The solution delivered a 35% reduction in data preparation time, a 3x productivity improvement, and enabled over 45 commercial use cases and 80 interactive dashboards, significantly improving operational efficiency and launch readiness for Emerging Pharma.

Emerging Pharma